The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions
- 29 November 1995
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 32 (16) , 1271-1281
- https://doi.org/10.1016/0161-5890(95)00085-2
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cardiogenic ShockNew England Journal of Medicine, 1994
- Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein llb/llla in patients undergoing elective coronary angioplastyCoronary Artery Disease, 1993
- Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the proteinCell, 1991
- Antiplatelet monoclonal F(ab′)2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heartJournal of Molecular and Cellular Cardiology, 1989
- Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs.Journal of Clinical Investigation, 1988
- Effects of monoclonal antibodies against the platelet glycoprotein IIb/IIIa complex on thrombosis and hemostasis in the baboon.Journal of Clinical Investigation, 1988
- Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis.Journal of Clinical Investigation, 1985
- The specificity of antibodies to the F(ab′)2 fragment of human IgGArthritis & Rheumatism, 1985
- Production of functional chimaeric mouse/human antibodyNature, 1984
- Anti‐γ‐Globulin Factors in Human Sera Revealed by Enzymatic Splitting of Anti‐Rh Antibodies*Vox Sanguinis, 1963